Cellectis S.A. (CLLS) — Earnings Call Analysis & IR Page

Cellectis S.A is a Healthcare company operating in Biotechnology with a $147.0M market cap.

Most recent earnings call: Q2 FY25 on Aug 5, 2025.

14 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

IR URL not yet extracted for CLLS.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 14 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CLLS.

$ curl https://api.spokenalpha.com/v1/companies/CLLS

Get an API key API docs

FAQ

Frequently asked about CLLS

Where can I find Cellectis S.A.'s (CLLS) earnings call transcripts?

Spoken Alpha indexes CLLS's earnings call transcripts at https://spokenalpha.com/companies/CLLS. Each call links to attributed speakers and parsed analyst Q&A.

When was Cellectis S.A.'s most recent earnings call?

Cellectis S.A. (CLLS) held its most recent earnings call on 2025-08-05, covering fiscal Q2 2025.

What sector is CLLS in?

Cellectis S.A. (CLLS) operates in the Healthcare sector (Biotechnology industry).

Overview